Biotechnology attracts much attention these days but few of us have more than a superficial knowledge of its complexities. There is potential for great benefit but concern about hazards. The positive side seldom interests the news media, and the language of biotechnology does not help. The very words 'genetic engineering' provoke unease. The term 'genctically modified organisms' ma)' well exacerbate matters for those of us who do not have all the necessary facts. What we need then is a handy reference text to turn to when the subject is being aired. And here it is, a work which should be read by all who write on health and anyone else w-ho wvants to form a balanced opinion.
The 182 pages of Genetic Engineering in Food Production contain the presentations of 25 authorities working in this area, plus some very useful editorial comment by way of a Foreword and a Summary. The potential benefits of the genetic modification of food animals and crops are listed. On page 149, a table sets out the possible exploitation (another loaded word) with regard to food animals. A similar table covering food crops wvould have been valuable. World population predictions up to the year 2050 are put forward as leaving us with little other option than to use genetic engineering to produce enough food to meet the needs of some 9-10 billion people. This leaves us with questions such as 'does it work?' 'is it safe?' and most important for many of us 'is it morally justifiable from the point of view of animal welfare?' In this last matter, we all draw the line somewhere, but not all in the same place. We have been manipulating Nature for a long time with animal and plant breeding. A wide variety of experts take us through the many) aspects of food animals (including fish) from the points of view of scientists, producers, retailers and control agencies arouncl the world. The attitude of the public is highlighted. It is no use producing food if there is no public confidence. Consumers take a more favourable view if they are well informed and are in a position to make their own choice. They also see a need for prudent regulatory control. The extent of the control which already exists might surprise some readers. As a starting point, I commend to you the chapter by the Rev Dr M Reiss who sets out all the issues in a lucid manner. This makes it easier to take in the detail of the high quality contributions in the rest of the book.
The work is the proceedings of a conference held bv the Roval Society of Medicine in February 1997. The transgenic sheep had not yet come to prominence, so 'Dolly' is not featured. I found the discussion a little limited but the book will surely be a valuable reference for a long time to come. I am told that people are reluctant to buy proceedings of meetings they did not attend. They should think again in this instance. This book is written principally by David Miller and its publication in the year before Ian McDonald's retirement is presumably not fortuitous. McDonald has written the first chapter, which is a lucid statement on the present use and uncertainty over MRI scanning in diagnosis, treatment evaluation and research on pathogenesis.
For those of us who listened to the Home Service, Light Programme and Third Programme on the wireless, and who have just been able to come to terms with Radio's 1-5 and VHF, the different MRI sequences offer little challenge not, at least, after one has read Miller's account of TI, T2, PD, FSE, FLAIR and fast FLAIR, gradient echo, STIR and magnetization transfer imaging. Early in the third chapter Miller rightly states 'A crucial point is that multiple sclerosis is diagnose(d primarily on clinical grounds. It should not be diagnosed from the results of MRI or any other laboratory investigation alone.' He then goes on to detail the spectrum of MRI abnormalities in MS.
MRI is very sensitive but has low specificity. Of control subjects between 50 and 59 years, as many as 30% had clear abnormalities and this rose to over 50% for those over 60 years. This serves to reinforce the fact that the diagnosis is made on clinical criteria. The list of conditions causing cerebral white matter lesions looking somewhat like those in multiple sclerosis is long, and reminds us that other conditions need to be considered. However, one study of 1500 consecutive patients using the MRI criteria for MS of the presence of three lesions and at least two of (a) a lesion greater than 5 mm (b) a periventricular lesion and (c) an infratentorial lesion, found a specificity of 96% and a sensitivity of 81%.
Unfortunately, the correlation between MRI scan appearance and functional (dis)ability is poor. The development of axonal loss seems to be implicated in the development of disability and Alan Thompson discusses the MRI changes in his chapter on pathogenesis and mechanisms of disability.
Early studies showed that sequential scanning could reveal changes on MRI which though obvious seemed to have no clinical effects. This is of potential use in treatment trials using MR as a surrogate marker. It is, however, difficult to know precisely what MRI parameters should be used. Undoubtedly gadolinium-enhanced TI scanning increases the finding of acute lesions. Hypointense lesions on TI scans are often more chronic and may be more related to disability. Total lesion load may be too blunt a measure even though there are semiautomated methods of measuring it. When we try to correlate the MRI changes with disability we must also bear in mind that the measure of disability may be too imprecise.
The book is well illustrated and is a clear statement of current knowledge and uncertainty. It will be of use not only to those with a specific interest in MS but also to all neurologists and neuroradiologists, at consultant and specialist registrar levels.
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